Position
CoreCap Advisors, LLC in Editas Medicine, Inc.
Back to the book · All holders of EDIT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $6$2.07 → $2.47
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 15 | $31 | — | — | — | 0.0% |
| Q1 2026 | 15 | $37 | $2.47 | $6 | $0 | 0.0% |